Chen Guo

Abstract Human health has been seriously endangered by arsenic pollution in drinking water. In this paper, iron hydroxide nanopetalines were synthesized through a precipitation method using KBH 4 and their performance and mechanism of As(V) and As(III) removal were investigated. The prepared material was characterized by SEM–EDX, XRD, BET, zeta potential and FTIR analyses. Batch experiments indicated that the iron hydroxide nanopetalines exhibited more excellent performance for As(V) and As(III) removal than ferrihydrite. The adsorption processes were very fast in the first stage, followed a relatively slower adsorption rate and reached equilibria after 24 h, and the reaction could be fitted best by the pseudo-second order model, followed by the Elovich model. The adsorption isotherm data followed to the Freundlich model, and the maximal adsorption capacities of As(V) and As(III) calculated by the Langmuir model were 217.76 and 91.74 mg/g at pH 4.0, respectively, whereas these values were 187.84 and 147.06 mg/g at pH 8.0, respectively. Thermodynamic studies indicated that the adsorption process was endothermic and spontaneous. The removal efficiencies of As(V) and As(III) were significantly affected by the solution pH and presence of PO 4 3– and citrate. The reusability experiments showed that more than 67% of the removal efficiency of As(V) could be easily recovered after four cycles. The SEM and XRD analyses indicated that the surface morphology and crystal structure before and after arsenic removal were stable. Based on the analyses of FTIR, XRD and XPS, the predominant adsorption mechanism was the formation of inner-sphere surface complexes by the surface hydroxyl exchange reactions of Fe–OH groups with arsenic species. This research provides a new strategy for the development of arsenic immobilization materials and the results confirm that iron hydroxide nanopetalines could be considered as a promising material for removing arsenic from As-contaminated water for their highly efficient performance and stability.

Arsenic (As(III)), more toxic and with less affinity than arsenate (As(V)), is hard to remove from the aqueous phase due to the lack of efficient adsorbents. In this study, a core–shell structured MnO2@La(OH)3 nanocomposite was synthesized via a facile two-step precipitation method. Its removal performance and mechanisms for As(V) and As(III) were investigated through batch adsorption experiments and a series of analysis methods including the transformation kinetics of arsenic species in As(III) removal, FTIR, XRD and XPS. Solution pH could significantly influence the removal efficiencies of arsenic. The adsorption process of As(V) occurred rapidly in the first 5 h and then gradually decreased, whereas the As(III) removal rate was relatively slower. The maximum adsorption capacities of As(V) and As(III) were up to 138.9 and 139.9 mg/g at pH 4.0, respectively. For As(V) removal, the inner-sphere complexes of lanthanum arsenate were formed through the ligand exchange reactions and coprecipitation. The oxidation of As(III) to the less toxic As(V) by δ-MnO2 and subsequently the synergistic adsorption process by the lanthanum hydroxide on the MnO2@La(OH)3 nanocomposite to form lanthanum arsenate were the dominant mechanisms of As(III) removal. XPS analysis indicated that approximately 20.6% of Mn in the nanocomposite after As(III) removal were Mn(II). Furthermore, a small amount of Mn(II) and La(III) were released into solution during the process of As(III) removal. These results confirm its efficient performance in the arsenic-containing water treatment, such as As(III)-contaminated groundwater used for irrigation and As(V)-contaminated industrial wastewater.

BACKGROUND: Metal ureteral stents (MUS) has gained popularity as an endoscopic treatment alternative for the management of ureteral strictures. The aim of this study was to evaluate the safety, efficacy, and tolerability of MUS for treating ureteral strictures and to identify any factors that could influence the success of this intervention. METHODS: This study is a prospective analysis of the efficacy and safety of MUS for treating ureteral strictures in a single-center setting. The study enrolled 246 patients who had been diagnosed with ureteral strictures and had undergone MUS placement between January 2019 and July 2021. The patients were followed-up for a duration of 2 years. RESULTS: The overall success rate of MUS placement was 71.7%. Furthermore, the success rate of ureteral strictures after kidney transplantation (78.2%) was significantly higher than common ureteral strictures (73.0%) or recurrent ureteral strictures (67.6%). Additionally, postsurgery, there was a considerable reduction in hydronephrosis volume (68.9±96.1 vs. 32.1±48.8 cm 3 ), blood creatinine level (103.7±49.8 vs. 94.4±47.5 mol/l) and urea nitrogen level (6.7±7.2 vs. 5.1±2.4 mmol/l). The study also reported that the rate of adverse events associated with MUS was relatively low, included hematuria (7.9%), pain (6.8%), urinary tract infection (6.4%), and lower urinary tract symptoms (5.3%). CONCLUSIONS: MUS appear to be a safe and effective treatment option for ureteral strictures, with a high success rate and low complication rate. These results have important implications for the management of ureteral strictures and can help guide clinical decision-making in the selection of treatment options.